203 related articles for article (PubMed ID: 24709455)
1. Ureaplasma and bronchopulmonary dysplasia.
Gancia P; Delogu A; Pomero G
Early Hum Dev; 2014 Mar; 90 Suppl 1():S39-41. PubMed ID: 24709455
[TBL] [Abstract][Full Text] [Related]
2. Ureaplasma infection and neonatal lung disease.
Schelonka RL; Waites KB
Semin Perinatol; 2007 Feb; 31(1):2-9. PubMed ID: 17317421
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of Ureaplasma urealyticum in bronchopulmonary dysplasia of prematurity].
Bao Y; Zhao ZY; Shi LP; Ma XL; Chen Z; Luo F
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):767-70. PubMed ID: 23302568
[TBL] [Abstract][Full Text] [Related]
4. Antenatal exposure to Ureaplasma species exacerbates bronchopulmonary dysplasia synergistically with subsequent prolonged mechanical ventilation in preterm infants.
Inatomi T; Oue S; Ogihara T; Hira S; Hasegawa M; Yamaoka S; Yasui M; Tamai H
Pediatr Res; 2012 Mar; 71(3):267-73. PubMed ID: 22258085
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants.
Ozdemir R; Erdeve O; Dizdar EA; Oguz SS; Uras N; Saygan S; Karabulut E; Dilmen U
Pediatrics; 2011 Dec; 128(6):e1496-501. PubMed ID: 22123897
[TBL] [Abstract][Full Text] [Related]
6. Ureaplasma and BPD.
Kallapur SG; Kramer BW; Jobe AH
Semin Perinatol; 2013 Apr; 37(2):94-101. PubMed ID: 23582963
[TBL] [Abstract][Full Text] [Related]
7. [Association of Ureaplasma urealyticum infection with bronchopulmonary dysplasia in very low birth weight infants with respiratory distress syndrome].
Chen Y; Ma LY; Huang Y; Huang SM; Xiao SQ; Lu GJ
Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):469-72. PubMed ID: 24856994
[TBL] [Abstract][Full Text] [Related]
8. Effect of antenatal azithromycin for Ureaplasma spp. on neonatal outcome at ≤30 weeks' gestational age.
Kim SH; Chun J; Ko KH; Sung TJ
Pediatr Int; 2019 Jan; 61(1):58-62. PubMed ID: 30460724
[TBL] [Abstract][Full Text] [Related]
9. Different degrees of maternal Ureaplasma colonization and its correlation with bronchopulmonary dysplasia in <32 weeks' preterm infants.
Chun J; Chun SH; Han YS; Sung TJ
Pediatr Neonatol; 2019 Aug; 60(4):441-446. PubMed ID: 30559061
[TBL] [Abstract][Full Text] [Related]
10. [Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter study].
Salcedo Abizanda S; Cabero Roura L; Andreu Domingo A; Lucaya Layret J; Perapoch López J; Casellas Caro M; Fernández Pérez F; Campins Martí M; Torán Fuentes N; Peguero Monforte G
An Esp Pediatr; 1997 Jun; Spec No 1():73-7. PubMed ID: 9382274
[No Abstract] [Full Text] [Related]
11. Ureaplasma urealyticum: no independent role in the pathogenesis of bronchopulmonary dysplasia.
Aaltonen R; Vahlberg T; Lehtonen L; Alanen A
Acta Obstet Gynecol Scand; 2006; 85(11):1354-9. PubMed ID: 17091417
[TBL] [Abstract][Full Text] [Related]
12. In utero exposure to Ureaplasma spp. is associated with increased rate of bronchopulmonary dysplasia and intraventricular hemorrhage in preterm infants.
Kasper DC; Mechtler TP; Böhm J; Petricevic L; Gleiss A; Spergser J; Witt A; Herkner KR; Berger A
J Perinat Med; 2011 May; 39(3):331-6. PubMed ID: 21526978
[TBL] [Abstract][Full Text] [Related]
13. A novel mouse model of Ureaplasma-induced perinatal inflammation: effects on lung and brain injury.
Normann E; Lacaze-Masmonteil T; Eaton F; Schwendimann L; Gressens P; Thébaud B
Pediatr Res; 2009 Apr; 65(4):430-6. PubMed ID: 19127208
[TBL] [Abstract][Full Text] [Related]
14. Association of Ureaplasma infection pattern and azithromycin treatment effect with bronchopulmonary dysplasia in Ureaplasma positive infants: a cohort study.
Chen X; Huang X; Lin Y; Lin B; Yang C; Huang Z; Yang C
BMC Pulm Med; 2023 Jun; 23(1):229. PubMed ID: 37365524
[TBL] [Abstract][Full Text] [Related]
15. Detection of ureaplasma DNA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors.
Colaizy TT; Morris CD; Lapidus J; Sklar RS; Pillers DA
Pediatr Res; 2007 May; 61(5 Pt 1):578-83. PubMed ID: 17413863
[TBL] [Abstract][Full Text] [Related]
16. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques.
Schelonka RL; Katz B; Waites KB; Benjamin DK
Pediatr Infect Dis J; 2005 Dec; 24(12):1033-9. PubMed ID: 16371861
[TBL] [Abstract][Full Text] [Related]
17. Randomised trial of azithromycin to eradicate
Viscardi RM; Terrin ML; Magder LS; Davis NL; Dulkerian SJ; Waites KB; Ambalavanan N; Kaufman DA; Donohue P; Tuttle DJ; Weitkamp JH; Hassan HE; Eddington ND
Arch Dis Child Fetal Neonatal Ed; 2020 Nov; 105(6):615-622. PubMed ID: 32170033
[TBL] [Abstract][Full Text] [Related]
18. Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey.
Pansieri C; Pandolfini C; Elie V; Turner MA; Kotecha S; Jacqz-Aigrain E; Bonati M
Sci Rep; 2014 Feb; 4():4076. PubMed ID: 24518104
[TBL] [Abstract][Full Text] [Related]
19. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial.
Ballard HO; Shook LA; Bernard P; Anstead MI; Kuhn R; Whitehead V; Grider D; Crawford TN; Hayes D
Pediatr Pulmonol; 2011 Feb; 46(2):111-8. PubMed ID: 20963840
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum.
Baier RJ; Loggins J; Kruger TE
J Investig Med; 2001 Jul; 49(4):362-9. PubMed ID: 11478413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
